‘Covaxin likely to be available for public use by Feb’
New Delhi (2 Min Read): Covaxin, the COVID vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration...
Covaxin
COVID-19 vaccine trial: 150 volunteers administered Covaxin in Kanpur
Kanpur: Medical experts administered indigenously developed COVID vaccine - Covaxin to 60 volunteers at Kanpur's Prakhar hospital on Monday. While...
Haryana health minister gets trial dose of Covid vaccine
Chandigarh: Haryana Health Minister Anil Vij was administered a trial dose of India-made coronavirus vaccine Covaxin on Friday. He was among...
Punjab to start Covaxin’s Phase-3 trials
Chandigarh: Punjab's three Government Medical Colleges will participate in the Phase-3 trials of Bharat Biotech Ltd's Covaxin, the first indigenously-developed vaccine...
COVAXIN’s animal trial gets robust immune responses: Bharat Biotech
New Delhi: Bharat Biotech International Limited has announced that its Covid-19 vaccine candidate, COVAXIN, has shown positive efficacy in animal studies...
Human clinical trial of ‘Covaxin’ begins in Odisha
Bhubaneswar: The human clinical trial of India's first possible anti-Covid vaccine 'Covaxin' began at an institute here on Monday, an...
COVAXIN, India’s 1st indigenous COVID-19 vaccine developed by Bharat Biotech successfully enters human clinical trials
Hyderabad: Hyderabad-based Bharat Biotech on Friday announced that the Phase-I clinical trials of India's first indigenous Covid-19 vaccine Covaxin began...
